Juha
Peltonen
Professor, Institute of Biomedicine
MD, PhD
Links
Areas of expertise
Neurofibromatosis
Cancer
Skin
Bone
Cell and Developmental Biology
Biography
EDUCATION
MD, University of Turku, Finland 1981;
PhD, University of Turku 1985;
Docentships:
•Medical Biochemistry, University of Turku 1990
•Anatomy, University of Oulu, Finland 1993
•Cell and developmental biology, University of Oulu 2009
Postdoc & foreign visits
Jefferson Institute of Molecular Medicine, Department of Dermatology, Thomas Jefferson University, Philadelphia, PA, USA, 1987-1990
Teaching
Cell Biology, Histology, Developmental biology, Gross anatomy
Research
Publications
Signaling pathways in human osteoclasts differentiation: ERK1/2 as a key player (2021)
Molecular Biology Reports
(A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä)
Circulating free DNA in the plasma of individuals with neurofibromatosis type 1 (2021)
American Journal of Medical Genetics Part A
(A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä)
Haploinsufficiency of the NF1 gene is associated with protection against diabetes (2020)
Journal of Medical Genetics
(A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä)
Density and function of actin-microdomains in healthy and NF1 deficient osteoclasts revealed by the combined use of atomic force and stimulated emission depletion microscopy (2020)
Journal of Physics D: Applied Physics
(A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä)
p53-Regulated Long Noncoding RNA PRECSIT Promotes Progression of Cutaneous Squamous Cell Carcinoma via STAT3 Signaling (2020)
American Journal of Pathology
(A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä)
A rare disease and education: Neurofibromatosis type 1 decreases educational attainment (2020)
Clinical Genetics
(A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä)
Correction: Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort study (Genetics in Medicine, (2019), 10.1038/s41436-019-0651-6) (2020)
Genetics in Medicine
(O2 Muu)
Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort study (2020)
Genetics in Medicine
(A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä)
Correction: Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort study (vol 45, pg 87, 209) (2020)
Genetics in Medicine
(O2 Muu)
Breast cancer risk in Neurofibromatosis type 1 is a function of the type of NF1 gene mutation: a new genotype-phenotype correlation (2019)
Journal of Medical Genetics
(A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä)